
Sign up to save your podcasts
Or


At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

135 Listeners

695 Listeners

495 Listeners

170 Listeners

102 Listeners

888 Listeners

13 Listeners

17 Listeners

292 Listeners

262 Listeners

3,331 Listeners

1,154 Listeners

196 Listeners

89 Listeners

514 Listeners

364 Listeners

171 Listeners

61 Listeners

8 Listeners

432 Listeners